OCP Is Leading Growth in the San Diego Life Science Community

Posted June 04, 2018 by OCP | Post a Comment

"Working with life science companies is not like serving other industries. There are myriad legal and financial eccentricities - accounting for multiple financing sources makes accounting especially complex, for instances and protecting intellectual property is key. Early-stage companies may need their hand held as they focus on the science and outsource everything else." San Diego Business Journal

(more…)

David H. Crean, Life Sciences, San Diego Life Science Investment Bank, Article

Objective Capital's David H. Crean Receives The 2018 Health Care Heros Award

Posted February 27, 2018 by OCP | Post a Comment

San Diego Business Journal Health Care Heros Award

San Diego, March 1, 2018 – The San Diego Business Journal’s 2018 Health Care Heroes Awards chose Objective Capital Partners’ David H. Crean, Ph.D. from among the finalists to receive the Health Care Hero Award for Company Executive for his role in healthcare innovation and support.

Leading Objective Capital Partners’ Life Sciences & Healthcare Investment Banking Practice, David leverages more than 20 years of life sciences R&D and corporate development experience. In his Managing Director role, David helps companies secure growth capital, establish strategic partnerships, and achieve exit transactions.

(more…)

News Announcement, David H. Crean, Healthcare, Life Sciences, San Diego

Objective Capital's David H. Crean Named 2017 Thought Leader of the Year

Posted January 29, 2018 by David Crean | Post a Comment

The Alliance of Merger & Acquisition Advisors® (AM&AA)

San Diego, January 30, 2018 — Objective Capital Partners, a middle-market M&A Advisory Firm located in Southern California, is pleased to announce that David H. Crean, Ph.D., Managing Director of the firm’s thriving Life Sciences and Healthcare practice, has been selected as the winner of the 2017 Thought Leader of the Year Award by The Alliance of Merger & Acquisition Advisors® (AM&AA).

The AM&AA recognized that “David’s thought leadership is materially expanding the investment banker’s role in serving life sciences companies and providing these companies with a highly attractive, non-diluting alternative to hard-to-secure venture capital financing.”

“We are observing life sciences and healthcare companies increasing engaging specialized investment banking teams with deep industry experience to gain a strategic advantage,” said Trever Acers, Managing Director at Objective Capital Partners.  “Specialized professionals such as David and his team members at Objective Capital are engaged by experienced Life Sciences executives to significantly improve the value, probability and speed of their M&A, strategic partnering, and growth capital objectives.  David is at the forefront of this change, leveraging his decades of industry experience with best-in-class investment banking capabilities to provide CEO with highly actionable strategic guidance."

(more…)

News Announcement, David H. Crean, Healthcare, Life Sciences, Middle Market, objective capital partners, Alliance of M&A Advisors, Alliance of Mergers & Acquisitions Advisors, Thought Leader, Thought Leader of the Year

Objective Capital’s David H. Crean Named 2017 Finalist for Thought Leader of the Year

Posted December 12, 2017 by David Crean | Post a Comment

San Diego, December 12, 2017 — Objective Capital Partners, a middle market M&A Advisory Firm located in Southern California, is pleased to announce that David H. Crean, Ph.D., one of its Managing Directors who heads its thriving life science and healthcare practice, has been selected as top five national finalist for the 2017 Thought Leader of the Year Award by The Alliance of Merger & Acquisition Advisors® (AM&AA). For more information on the Award and the Finalists, please visit http://www.amaaonline.com/thought-leader-of-the-year/

(more…)

David H. Crean, Healthcare, Life Sciences, objective capital partners, Alliance of M&A Advisors, Thought Leader of the Year, Uncategorized

Bio Buck$ Fast Forward: A Start-up’s Guide to Investment Banks

Posted November 05, 2017 by David Crean | Post a Comment

Objective Capital’s David H. Crean to Serve as Guest Panelist at LaunchBio Event, November 14, 2017

San Diego, November 9, 2017 — Objective Capital Partners, a middle market M&A Advisory Firm located in Southern California, is pleased to announce that David H. Crean, Ph.D., one of its Managing Directors who heads its thriving life science and healthcare practice, has been invited to speak as a guest panelist at LaunchBio Series Event for life science companies entitled BIO Buck$ Fast Forward: A Start-ups Guide to Investment Banks. Dr. Crean will be joined by Charlie Adams, Cantor Fitzgerald and Tony Grover, VP of Business Development at Banyan Biomarker.

(more…)

Capital Financing, m&A, BioBucks, David H. Crean, Entrepreneurs, LaunchBio, Partnering, Start-ups, Investment banking, life science, Uncategorized

SoCal Capital Summit on M&A Healthcare Trends & Opportunities

Posted November 04, 2017 by David Crean | Post a Comment

 

Objective Capital’s David H. Crean to be Guest Panelist at ACG Orange County's CEO Signature Event on November 15, 2017

San Diego, November 6, 2017 — Objective Capital Partners, a middle-market M&A Advisory Firm located in Southern California, is pleased to announce that David H. Crean, Ph.D., one of its Managing Directors who heads its thriving life science and healthcare practice, will be a guest panelist speaker at ACG Orange County’s CEO Signature Event entitled SoCal Capital Summit on November 15, 2017.   Dr. Crean and the fellow panelists will address M&A Healthcare Trends and Opportunities.  He will be joined by Greg Cunniff, CFO, NVISION Eye Centers, and Steven Shill, Partner and National Healthcare Practice Leader at BDO.

(more…)

Healthcare & Life Sciences, David H. Crean, Life Sciences, M&A Trends, SoCal Capital Summit, ACG Orange County, Uncategorized

Objective Capital Partners Wins Four Awards at Advisor of the Year 2017

Posted October 30, 2017 by David Crean | Post a Comment

SAN DIEGO (October 30, 2017) — Objective Capital Partners, a middle-market M&A Advisory Firm located in Southern California, is pleased to announce that it has been awarded four Advisor of the Year awards including Best Sell-side Representation by an Investment Banker for a transaction more than $25M. Objective Capital won the Advisor of the Year awards in the following categories:

  • Best Sell-side Representation by an Investment Banker more than $25M for its advisory of GunVault and Cannon Safe in its sale to MidOcean Partners;
  • Best Sell-side Representation by an Investment Banker less than $25M for its advisory of Troxel Helmets in its sale to Weaver Leather;
  • Special Situation Advisory for its advisory of Minimal Invasive Devices in its sale to Cagan McAfee Capital Partners;
  • Contribution related to Valuation for its advisory to the internal sale of an undisclosed business services company.

(more…)

Trever Acers, Channing Hamlet, David H. Crean, Michael Kim, objective capital partners, Sell-side Investment Banking, Valuation, Advisor of the Year, Special Situation Advisory, Uncategorized

ACG San Diego Elects Objective Capital Partners’ Crean to Its Board of Directors

Posted July 28, 2017 by David Crean | Post a Comment

Managing Director to Serve as Chair of Marketing Committee

San Diego, CA- August 1, 2017 - Objective Capital Partners, a leading M&A investment banking firm specializing in middle market M&A, healthcare & life sciences and valuation advisory services, is pleased to announce that one of its Managing Directors, David H. Crean, Ph.D., was elected to serve on the Board of Directors for the San Diego Chapter of the Association for Corporate Growth (ACG San Diego).  The Chapter also added Jay Robinson-Duff, VP, First American Trust to its Board.  Dr. Crean has been a member of ACG for the past two years and will lead the Chapter’s marketing efforts.  At Objective Capital Partners, he is responsible for the firm's strategy targeted at companies in the Healthcare and Life Sciences sector including pharmaceutical, biotechnology, medical technology, medical device, supplies, manufacturing and life science tools/ diagnostic firms looking for M&A, partnering, strategic advisory and capital financing options.

(more…)

Board of Directors, ACG San Diego, David H. Crean, objective capital partners, Uncategorized

Objective Capital’s Dr. David Crean to Address Entrepreneurs on Due Diligence Issues

Posted June 15, 2017 by David Crean | Post a Comment

San Diego Startup Week — June 19th - 23rd, 2017

San Diego, CA- June 19, 2017 - Objective Capital Partners, a leading M&A investment banking firm specializing in middle-market M&A and capital raise, healthcare & life sciences and valuation advisory services, is pleased to announce that one of its Managing Directors, David H. Crean, Ph.D., will be a panel speaker as part of San Diego Startup Week on June 19-23, 2017 in San Diego, CA. Dr. Crean will address issues to consider on due diligence from an investment banker’s perspective on June 21, 2017. He will be joined by fellow panelists Jeremy Glaser, Attorney and Partner at Mintz Levin, Brent Grenado, General Partner at Sway Ventures, Patrick Henry, CEO at Quest Fusion, and Walt Tendler, CFO at Mission Venture.

(more…)

Due Diligence, Licensing, mergers & Acquisitions, David H. Crean, objective capital partners, Start-ups, Start-Up Week San Diego, Uncategorized

Objective Capital’s Dr. David Crean to Judge Life Sciences Company Pitches at Start-Up Stadium 2017

Posted June 07, 2017 by David Crean | Post a Comment

Start-up and Emerging Companies to Present at BIO2017

San Diego, CA- June 12, 2017 - Objective Capital Partners, a leading M&A investment banking firm specializing in middle-market M&A and capital raise, healthcare & life sciences and valuation advisory services, is pleased to announce that one of its Managing Directors, David H. Crean, Ph.D., will serve as a Judge for company finalists during live presentations as part of BIO 2017 Start-Up Stadium on June 20-22, 2017 in San Diego, CA. As the world’s largest biotechnology event, the BIO International Convention provides several specialized opportunities geared towards start-up and emerging companies. The Start-Up Stadium was designed to provide start-up companies with the opportunity to engage key members of the investment community, venture philanthropy groups, and BIO attendees.

(more…)

BIO2017, Biotechnology, Biotechnology Innovation Organization, Start Up Companies, BIO, David H. Crean, Life Sciences, objective capital partners, Start-Up Stadium, Uncategorized

This article is provided for informational purposes only and does not constitute an offer, invitation or recommendation to buy, sell, subscribe for or issue any securities. While the information provided herein is believed to be accurate and reliable, Objective Capital Partners and BA Securities, LLC makes no representations or warranties, expressed or implied, as to the accuracy or completeness of such information. It should not be construed as investment, legal, or tax advice and may not be reproduced or distributed to any person.

Our Services

Learn about our services and how we can help you sell your business successfully.

LEARN MORE

Contact Us

San Diego Office:
3636 Nobel Dr., Suite 160
San Diego, CA 92122

Los Angeles Office:
10100 Santa Monica Blvd., Suite 300
Los Angeles, CA 90067

Trever Acers
Managing Director
858.663.8662 telephone
trever.acers@objectivecp.com

Channing Hamlet
Managing Director
858.342.4939 telephone
channing.hamlet@objectivecp.com

David H. Crean, Ph.D.
Managing Director
858.461.9490 telephone
david.crean@objectivecp.com

Jack J. Florio
Managing Director
858.864.4339 telephone
jack.florio@objectivecp.com